47
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Availability and readability of patient education materials for deprescribing: An environmental scan

      review-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims

          To identify and evaluate content and readability of freely available online deprescribing patient education materials (PEMs).

          Methods

          Systematic review of PEMs using MEDLINE, Embase, CINAHL, PsycINFO and The Cochrane Library of Systematic Reviews from inception to 25 September 2017 to identify PEMs. Additionally, deprescribing researchers and health professionals were surveyed to identify additional materials. Known repositories of materials were searched followed by a systematic Google search (22–28 January 2018). Materials were evaluated using an approach informed by the Patient Education Material Assessment Tool and the International Patient Decision Aids Standards Inventory. Readability of text‐based materials was assessed using the US‐based Gunning–Fog Index and Flesch–Kincaid Grade level.

          Results

          Forty‐eight PEMs were identified. PEMs addressing deprescribing of medications for symptom control (81%) were most common. Preventative medications were rarely addressed and material (39%) focused on older people. Only 37% of PEMs provided information about both potential benefits (e.g. reducing risk of side effects) and harms (e.g. withdrawal symptoms, increased risk of disease) of deprescribing, while 40% focussed on benefits only. Readability indices indicated an average minimum reading level of Grade 12. Option Grids and Decision Aids (mean reading level below Grade 10) were most suitable for people with average literacy levels.

          Conclusions

          Over 1/3 of deprescribing PEMs present potential benefits and harms of deprescribing indicating most of the freely available materials are not balanced. Most PEMs are pitched above average reading levels making them inaccessible for low health literacy populations.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          Patient barriers to and enablers of deprescribing: a systematic review.

          Inappropriate medication use is common in the elderly and the risks associated with their use are well known. The term deprescribing has been utilised to describe the complex process that is required for the safe and effective cessation of inappropriate medications. Given the primacy of the consumer in health care, their views must be central in the development of any deprescribing process. The aim of this study was to identify barriers and enablers that may influence a patient's decision to cease a medication. A systematic search of MEDLINE, International Pharmaceutical Abstracts, EMBASE, CINAHL, Informit and Scopus was conducted and augmented with a manual search. Numerous search terms relating to withdrawal of medications and consumers' beliefs were utilised. Articles were included if the barriers or enablers were directly patient/carer reported and related to long-term medication(s) that they were currently taking or had recently ceased. Determination of relevance and data extraction was performed independently by two reviewers. Content analysis with coding was utilised for synthesis of results. Twenty-one articles met the criteria and were included in the review. Three themes, disagreement/agreement with 'appropriateness' of cessation, absence/presence of a 'process' for cessation, and negative/positive 'influences' to cease medication, were identified as both potential barriers and enablers, with 'fear' of cessation and 'dislike' of medications as a fourth barrier and enabler, respectively. The most common barrier/enabler identified was 'appropriateness' of cessation, with 15 studies identifying this as a barrier and 18 as an enabler. The decision to stop a medication by an individual is influenced by multiple competing barriers and enablers. Knowledge of these will aid in the development of a deprescribing process, particularly in approaching the topic of cessation with the patient and what process should be utilised. However, further research is required to determine if the proposed patient-centred deprescribing process will result in improved patient outcomes.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.

            Deprescribing is a suggested intervention to reverse the potential iatrogenic harms of inappropriate polypharmacy. The review aimed to determine whether or not deprescribing is a safe, effective and feasible intervention to modify mortality and health outcomes in older adults.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Presenting quantitative information about decision outcomes: a risk communication primer for patient decision aid developers

              Background Making evidence-based decisions often requires comparison of two or more options. Research-based evidence may exist which quantifies how likely the outcomes are for each option. Understanding these numeric estimates improves patients’ risk perception and leads to better informed decision making. This paper summarises current “best practices” in communication of evidence-based numeric outcomes for developers of patient decision aids (PtDAs) and other health communication tools. Method An expert consensus group of fourteen researchers from North America, Europe, and Australasia identified eleven main issues in risk communication. Two experts for each issue wrote a “state of the art” summary of best evidence, drawing on the PtDA, health, psychological, and broader scientific literature. In addition, commonly used terms were defined and a set of guiding principles and key messages derived from the results. Results The eleven key components of risk communication were: 1) Presenting the chance an event will occur; 2) Presenting changes in numeric outcomes; 3) Outcome estimates for test and screening decisions; 4) Numeric estimates in context and with evaluative labels; 5) Conveying uncertainty; 6) Visual formats; 7) Tailoring estimates; 8) Formats for understanding outcomes over time; 9) Narrative methods for conveying the chance of an event; 10) Important skills for understanding numerical estimates; and 11) Interactive web-based formats. Guiding principles from the evidence summaries advise that risk communication formats should reflect the task required of the user, should always define a relevant reference class (i.e., denominator) over time, should aim to use a consistent format throughout documents, should avoid “1 in x” formats and variable denominators, consider the magnitude of numbers used and the possibility of format bias, and should take into account the numeracy and graph literacy of the audience. Conclusion A substantial and rapidly expanding evidence base exists for risk communication. Developers of tools to facilitate evidence-based decision making should apply these principles to improve the quality of risk communication in practice.
                Bookmark

                Author and article information

                Contributors
                jesse.jansen@sydney.edu.au
                Journal
                Br J Clin Pharmacol
                Br J Clin Pharmacol
                10.1111/(ISSN)1365-2125
                BCP
                British Journal of Clinical Pharmacology
                John Wiley and Sons Inc. (Hoboken )
                0306-5251
                1365-2125
                07 May 2019
                July 2019
                : 85
                : 7 ( doiID: 10.1111/bcp.v85.7 )
                : 1396-1406
                Affiliations
                [ 1 ] Sydney School of Public Health, ASK‐GP Centre of Research Excellence The University of Sydney NSW Australia
                [ 2 ] Wiser Health Care The University of Sydney Sydney NSW Australia
                [ 3 ] Sydney Health Literacy Lab, Sydney School of Public Health The University of Sydney NSW Australia
                [ 4 ] School of Pharmacy and Charles Perkins Centre The University of Sydney Sydney NSW Australia
                Author notes
                [*] [* ] Correspondence

                Dr Jesse Jansen, The University of Sydney, Sydney School of Public Health, ASK‐GP Centre of Research Excellence, Edward Ford Building (A27) Room 126A, NSW 2006, Australia.

                Email: jesse.jansen@ 123456sydney.edu.au

                Author information
                https://orcid.org/0000-0002-1302-009X
                http://orcid.org/0000-0002-7739-0049
                Article
                PMC6595308 PMC6595308 6595308 BCP13912 REV-00841-18.R2
                10.1111/bcp.13912
                6595308
                30848837
                167ad8cb-c8af-4988-afef-4b2fd2d1e5bd
                © 2019 The British Pharmacological Society
                History
                : 18 November 2018
                : 27 February 2019
                : 28 February 2019
                Page count
                Figures: 2, Tables: 3, Pages: 11, Words: 4983
                Funding
                Funded by: National Health and Medical Research Council
                Award ID: Centre for Research Excellence: “Ask, Share Know
                Award ID: Dementia Leadership Fellowship (1136849)
                Award ID: Early Career Fellowship (1037028)
                Funded by: National Heart Foundation of Australia
                Award ID: Vanguard Grant 101326
                Funded by: Royal Australian College of General Practitioners
                Award ID: Research Grant TGL16b
                Funded by: Sydney Medical School
                Award ID: ECR PhD scholarship
                Funded by: Therapeutic Guidelines
                Award ID: Research Grant TGL16b
                Categories
                Systematic Review and Meta‐analysis
                Systematic Review and Meta‐analysis
                Custom metadata
                2.0
                bcp13912
                July 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.5 mode:remove_FC converted:27.06.2019

                patient education,deprescribing,health literacy
                patient education, deprescribing, health literacy

                Comments

                Comment on this article